Annual result

Swiss Transfusion SRC closes 2022 with a loss.

Blood donation

The blood supply division closed 2022 with a loss of almost CHF 300,000. This was primarily due to losses on securities and the reduction in the amount of contributions from the regional blood transfusion services.

A large part of the losses on securities could be covered by transferring funds out of the blood supply division’s reserve for fluctuations in asset values, thereby reducing this reserve to CHF 150,000. Along with the withdrawal of CHF 101,730 from the “National assigned duties risk” reserve, the remaining loss of CHF 186,337 can be covered using non-committed funds and operating funds.

Blood stem cells

Income from the core blood stem cell services decreased, as planned, as various flat-rate fees were reduced going into 2022. Despite the lowered fees, the division earned a positive operating result of more than one million Swiss francs. This was thanks in particular to higher case numbers with regard to both patient- and donor-related services (“Income from donor searches and transplants”). Had it not been possible to transfer some of the funds out of the reserve for fluctuations in asset values, the division would have closed with a significant loss due to the negative financial result.


Swiss Transfusion SRC’s mandate from the Swiss government to provide services in the area of blood stem cells does not include any funding for the registration of new donors; Swiss Transfusion SRC has to cover these expenses itself. Total registration costs per donor are CHF 140.

Almost three-quarters of income in the form of monetary donations came from private individuals, associations and companies, the other quarter came from institutional donors. The renewal rate for benefactorships was 80% in 2022.


The 2022 financial statement shows a loss due to the poor performance of the stock market in 2022.

The annual financial statement was audited by the auditors Ernst & Young according to the Swiss GAAP FER standards and the principles of the limited audit. The annual financial statements are available in German and French.